ArticleCancer chemotherapy and pharmacology2021

PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1.

Shuo Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.